Motilal Oswal's research report on SRF
SRF posted a decent overall performance in 3QFY25. However, the Chemicals business and the Packaging Films business displayed material improvement during the quarter. Margins for the Chemicals business improved 120bp/ 620bp YoY/QoQ, while the same for the Packaging Films business improved 240bp/70bp YoY/QoQ. The overall macro scenario is showing some signs of revival for the Chemicals business (67% EBIT mix in FY25E), coupled with management’s expectation of strong sequential growth in 4QFY25 with further improvement from FY26. This will be led by a healthy launch pipeline and demand recovery in specialty chemicals, a ramp-up of exports/domestic volumes in the Fluorochemicals business and pricing improvement in the overall chemicals business.
Outlook
We upgrade SRF to BUY from Neutral, valuing the stock on an SoTP basis to arrive at our TP of INR3,540.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.